Abortion provider BPAS under attack from hackers

Following the arrest of a hacker who planned to publish women's details, there have been 2,500 attem

Last week, a 27 year old man was jailed for stealing the personal details of 10,000 women from Britain’s largest pregnancy advisory clinic.

James Jeffery, a member of the hacking collective Anonymous, planned to publish the names, email addresses and telephone numbers of these women, which he took from the website of the British Pregnancy Advisory Service (BPAS). He pleaded guilty and was sentenced to two years and eight months in jail at Southwark Crown Court.

But the risk to BPAS is far from removed. Indeed, the BBC reports this morning that in the five weeks since Jeffery’s arrest, a mind-boggling 2,500 attempts have been made to hack into the advisory service's computer systems.

As yet, none of these attempts have been successful, and BPAS has reassured women that their details are safe. But this is a seriously worrying development. Around 60,000 women contact BPAS each year, and 53,000 have abortions under their supervision. Their privacy is paramount. Sentencing Jeffery, Judge Malcolm Gledhill spoke of the potentially “terrible consequences” of the women's details being published:

Many of them were vulnerable women, vulnerable simply because they had had a termination or because of their youth or because their family did not know about their situation.

That is quite apart from the risk to their personal safety from anti-abortion activists.

So where are these latest hacking attempts coming from? It is difficult to say. The IP addresses suggest that almost half of the computers used during these hacking attempts come from the US. However, as the BBC points out, the nature of hacking means it is impossible to say with any certainty that this means the hackers are US-based.

The US is home to a far more virulent and live debate on abortion than we currently see in the UK, but there is serious cause for concern about the direction of travel on home shores. Elements of government are undeniably hostile to abortion. Hardcore anti-abortion backbenchers like Nadine Dorries are encouraged by sympathetic ministers like Andrew Lansley. Dorries’ proposals on  that women undertake independent counselling before they are allowed to have an abortion has been adopted by the Department of Health despite the fact that the Commons voted against it. Lansley recently announced spot checks on abortion clinics – including those run by BPAS – after reports that a small number of doctors were pre-signing consent forms to circumvent the rule that states that two doctors must attest a woman’s sanity before an abortion is allowed.

Clearly, the assault on BPAS’s cyber-security is something else altogether – a renegade, bottom-up attack by what appears to be a collection of individuals rather than an organised political force.

But it is a reminder that the battle on abortion is not yet won. Emily Thornberry, the shadow attorney general and a pro-choice campaigner, has called for the police to prosecute anyone who attempts to break in to BPAS’s computers. She was right to do so. Whether the attacks are coming from hackers or ministers, the law must protect women’s rights to both abortion and to medical privacy.
 

An anti-abortion rally outside Parliament. London, 2007. Photograph: Getty Images

Samira Shackle is a freelance journalist, who tweets @samirashackle. She was formerly a staff writer for the New Statesman.

Joe Raedle/Getty Images
Show Hide image

“Stop treating antibiotics like sweets”: the threat we face from antibioitic resistance

Currently, 700,000 people die per year from the resistance of microbes to medicine, and it is predicted that 10 million people will die per year by 2050.

Got a cold? Take some antibiotics. Feeling under the weather? Penicillin will patch you up. Or so the common advice goes. However, unless we start to rethink our dependency on antibiotics, a death every three seconds is the threat we potentially face from evolving resistance by microorganisms to the drugs. The stark warning was issued following a review which analysed the consequences we could face from needless administering of antibiotics.

The antimicrobial resistance (AMR) review was led by economist Jim O’Neill, who was tasked by the prime minister in 2014 with investigating the impact of growing resistance. Currently, 700,000 people die per year from the resistance of microbes to medicine, and the report predicts that 10 million people will die per year by 2050. An overwhelming global expense of $100trn will be the price to pay unless incisive, collaborative action is taken.

Antimicrobial resistance (as referred to in the title of the report) is an umbrella term for the resistance developed by microorganisms to drugs specifically designed to combat the infections they cause. Microorganisms include things such as bacteria, fungi, viruses and parasites. The report especially focused on the ramifications of increased resistance of microorganisms to anitbiotics.

Many medical procedures are dependent on the effectiveness of drugs such as antibiotics: treatments for cancer patients and antibiotic prophylaxis during surgeries, for example. All could be under threat by increased resistance. The continuing rise of resistant superbugs and the impotence of antibiotics would pose “as big a risk as terrorism”. A post-antibiotic world would spell dystopia.

Bacterial microbes develop resistance through evolutionary-based natural selection. Mutations to their genetic makeup are passed on to other bacteria through an exchange of plasmid DNA. Unnecessary prescriptions by doctors and inappropriate antibiotic usage by patients (such as half-finishing a course) also contribute. Over the years, a number of bacteria and viruses have found a way to counteract antibiotics used against them: E. Coli, malaria, tuberculosis and Staphylococcus aureus, to name a few.

The report employed the consultancy firms KPMG and Rand to undertake the analyses, and O’Neill outlines 10 different measures to tackle the issue. Key areas of focus include: global campaigns to expand public awareness, the upholding of financial and economic measures by pharmaceutical companies in the development of new medicines and vaccines as alternatives, greater sanitation to prevent infections spreading, and the creation of a Global Innovation Fund which will enable collective research.

O’Neill told the BBC:

“We need to inform in different ways, all over the world, why it’s crucial we stop treating our antibiotics like sweets. If we don’t solve the problem we are heading to the dark ages; we will have a lot of people dying. We have made some pretty challenging recommendations which require everybody to get out of the comfort zone, because if we don’t then we aren’t going to be able to solve this problem.”

In the foreword of the report, O’Neill states that over 1 million people have died from developing resistance since 2014. The urgency in tackling this issue is clear, which is why he has offered an incentive to companies to develop new treatments - a reward of more than $1 billion will be given to those who bring a successful new treatment to the market.

According to the report, the cost of successful global action would equate to $40bn over the next decade, which could result in the development of 15 new antibiotics. Small cuts to health budgets and a tax on antibiotics have been proposed as ways of achieving the financial quota for drug research.

Though the report has highlighted the severity of antibiotic resistance, some believe that the full extent of the matter isn’t sufficiently explored. O’Neill mentions that there are some secondary effects which haven’t been taken into account “such as the risks in carrying out caesarean sections, hip replacements, or gut surgery”. This suggests that alternative remedies should be found for non-surgical procedures, so that antibiotics aren’t made redundant in environments where they are most needed.

Since the analysis began in 2014, new types of resistance have surfaced, including a resistance to colistin, a drug which is currently used as a last-resort. Its affordability resulted in increased use, particularly as a component of animal feed, meaning greater opportunity for superbugs to develop resistance to even our most dependable of antibiotics.

Widespread drug resistance would prove to be a big issue for many charities tackling infections around the world. Dr Grania Bridgen from Médecins Sans Frontières told the BBC that the report addresses a “broad market failure”, which is important but isn’t enough.

Despite the mixed response to the report, it has had a seal of approval from the Wellcome Trust and the Department of Health. Speaking earlier this year, Chancellor George Osborne stated this issue “is not just a health problem but an economic one, too. The cost of doing nothing, both in terms of lives lost and money wasted, is too great, and the world needs to come together to agree a common approach.”

If antibiotics are to remain potent antidotes to infectious diseases in the future, we need to put a plan in motion now.